CC
BRLI

Chase Coleman’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Chase Coleman’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-720,000
Closed -$23.1M – 66
2014
Q4 		$23.1M Hold
720,000
– – 0.27% 44
2014
Q3 		$20.2M Hold
720,000
– – 0.27% 35
2014
Q2 		$21.8M Hold
720,000
– – 0.28% 37
2014
Q1 		$19.9M Hold
720,000
– – 0.27% 40
2013
Q4 		$18.4M Hold
720,000
– – 0.23% 48
2013
Q3 		$21.5M Hold
720,000
– – 0.36% 32
2013
Q2 		$20.7M Buy
+720,000
New +$19.8M 0.36% 37

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Chase Coleman's BRLI Position: Q1 2015 in Review

Chase Coleman sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q1 2015, closing a stake of 720,000 shares — an estimated $23.1M sold.

Chase Coleman first reported a position in BRLI in Q2 2013 and held it in 7 quarters. The position peaked at $23.1M in Q4 2014. 168 funds tracked by Wall St. Rank hold BRLI as of Q1 2015.

  • Chase Coleman reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q1 2015 after selling out during the quarter.
  • Chase Coleman sold 720,000 BIO-REFERENCE LABS INC-NEW- shares in Q1 2015, an estimated $23.1M.
  • Chase Coleman first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 7 quarters.
  • Chase Coleman's BIO-REFERENCE LABS INC-NEW- position peaked at $23.1M in Q4 2014.
  • 168 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q1 2015.

Based on Tiger Global Management's 13F filing for Q1 2015, filed 15 May 2015.